Chromoblastomycosis.
Chromoblastomycosis, together with phaeohyphomycosis and mycetoma, makes up the disease entities caused by the dematiaceous fungi. Most cases of chromoblastomycosis are caused by five genera of fungi: Fonsecaea compactum, Fonsecaea pedrosoi, Phialophora verrucosa, Cladosporium carrionii, and Rhino-cladiella aquaspersa. The disease has a cosmopolitan distribution but predominates in rural, agricultural settings. Clinically, chromoblastomycosis is hallmarked by verrucous nodules at the site of fungal implantation. Treatment involves surgical excision of the affected area, antimycotic agents, physical modalities such as temperature manipulation, or a combination of these.
Milam
C P
CP
Department of Internal Medicine, University of South Florida College of Medicine, Tampa.
Fenske
N A
NA
D000328:Adult; D000935:Antifungal Agents / Q000627:therapeutic use; D002862:Chromoblastomycosis / Q000188:drug therapy / Q000453:epidemiology / Q000266:history / Q000382:microbiology; D003881:Dermatomycoses / Q000473:pathology; D003937:Diagnosis, Differential; D005121:Extremities; D005260:Female; D049673:History, 20th Century; D006801:Humans; D008297:Male; D012423:Rural Health; D012737:Sex Factors; D009626:Terminology as Topic; D013997:Time Factors; D014329:Tropical Climate / Q000009:adverse effects
D000935:Antifungal Agents